These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8846230)

  • 1. Calbindin-D28k-containing neurons in the human hypothalamus: relationship to dopaminergic neurons.
    Sanghera MK; Zamora JL; German DC
    Neurodegeneration; 1995 Dec; 4(4):375-81. PubMed ID: 8846230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sparing of the dopaminergic neurons containing calbindin-D28k and of the dopaminergic mesocortical projections in weaver mutant mice.
    Gaspar P; Ben Jelloun N; Febvret A
    Neuroscience; 1994 Jul; 61(2):293-305. PubMed ID: 7969910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calretinin and calbindin-D28k in dopaminergic neurons of the rat midbrain: a triple-labeling immunohistochemical study.
    Nemoto C; Hida T; Arai R
    Brain Res; 1999 Oct; 846(1):129-36. PubMed ID: 10536220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in calbindin-D28k expression in oxytocin-containing magnocellular neurons of the rat hypothalamus.
    Arai R; Jacobowitz DM; Deura S
    Histochemistry; 1994 Jan; 101(1):9-12. PubMed ID: 7517930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28K and calretinin.
    Liang CL; Sinton CM; German DC
    Neuroscience; 1996 Nov; 75(2):523-33. PubMed ID: 8931015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of calretinin, calbindin-D28k and parvalbumin in the hypothalamus of the squirrel monkey.
    Fortin M; Parent A
    J Chem Neuroanat; 1997 Dec; 14(1):51-61. PubMed ID: 9498166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vulnerability of midbrain dopaminergic neurons in calbindin-D28k-deficient mice: lack of evidence for a neuroprotective role of endogenous calbindin in MPTP-treated and weaver mice.
    Airaksinen MS; Thoenen H; Meyer M
    Eur J Neurosci; 1997 Jan; 9(1):120-7. PubMed ID: 9042576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration.
    McCormack AL; Atienza JG; Langston JW; Di Monte DA
    Neuroscience; 2006 Aug; 141(2):929-937. PubMed ID: 16677770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans.
    McRitchie DA; Hardman CD; Halliday GM
    J Comp Neurol; 1996 Jan; 364(1):121-50. PubMed ID: 8789281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroactive peptides exist in the midbrain dopaminergic neurons that contain calbindin-D28k.
    German DC; Liang CL
    Neuroreport; 1993 May; 4(5):491-4. PubMed ID: 8513124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colocalization of calbindin-D28k with vasopressin in hypothalamic cells of the rat: a double-labeling immunofluorescence study.
    Arai R; Jacobowitz DM; Deura S
    Brain Res; 1993 Dec; 632(1-2):342-5. PubMed ID: 8149243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration.
    Liang CL; Sinton CM; Sonsalla PK; German DC
    Neurodegeneration; 1996 Dec; 5(4):313-8. PubMed ID: 9117542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of alkaline phosphatase in situ hybridization with immunohistochemistry: colocalization of calretinin-mRNA with calbindin and tyrosine hydroxylase immunoreactivity in rat substantia nigra neurons.
    Heppelmann B; Señaris R; Emson PC
    Brain Res; 1994 Jan; 635(1-2):293-9. PubMed ID: 7909717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease.
    Gibb WR
    Brain Res; 1992 May; 581(2):283-91. PubMed ID: 1382801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.
    Yamada T; McGeer PL; Baimbridge KG; McGeer EG
    Brain Res; 1990 Sep; 526(2):303-7. PubMed ID: 2257487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calbindin-D28k in nerve cell nuclei.
    German DC; Ng MC; Liang CL; McMahon A; Iacopino AM
    Neuroscience; 1997 Dec; 81(3):735-43. PubMed ID: 9316025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calbindin D28K as a marker for the degeneration of the striatonigral pathway in Huntington's disease.
    Kiyama H; Seto-Ohshima A; Emson PC
    Brain Res; 1990 Aug; 525(2):209-14. PubMed ID: 2147568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased calbindin-D28k immunoreactivity in aged rat sympathetic pelvic ganglionic neurons.
    Corns RA; Boolaky UV; Santer RM
    Neurosci Lett; 2000 Oct; 292(2):91-4. PubMed ID: 10998556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?
    Mouatt-Prigent A; Agid Y; Hirsch EC
    Brain Res; 1994 Dec; 668(1-2):62-70. PubMed ID: 7704619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple colocalization of tyrosine hydroxylase, calretinin, and calbindin D-28k in the periventricular-hypophyseal dopaminergic neuronal system.
    Jacobowitz DM; Isaacs KR; Cimini V
    Adv Pharmacol; 1998; 42():37-40. PubMed ID: 9327840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.